Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
Advertisement
The Scientist
Most Recent
Dengue virus has sophisticated mechanisms for entering a cell, for replicating its RNA genome, and for transcribing proteins.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
The editor-in-chief of the open access journal Retrovirology has passed away unexpectedly.
Tuberculosis bacteria find shelter from drugs and the body’s defenses in bone marrow stem cells.
Meet the bacterium that pulls gold ions out of solution and forms tiny nuggets of the precious metal.
Using a SMART card containing your genetic information and medical history, you could one day soon be diagnosed and treated for all kinds of diseases at an ATM-style kiosk.
As cholera first tore through the Europe in the mid-19th century, people tried anything to prevent the deadly disease. Then science stepped in.
Contributors
| February 1, 2013
Meet some of the people featured in the February 2013 issue of The Scientist.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
